Enanta Pharmaceuticals Inc (ENTA)
$7.00 -$1.32 (-15.22%) 4:38 PM 12/11/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$169.55M -
Day's Range
$7.06 - $8.74 -
Volume
481,838 -
52 Week Low / High
$7.86 - $17.80 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
ENTA's Dividend
Hypothetical 10k Investment Jan 1, 2020
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
Analyists Ranking
- 2
- Strong Buy
- 2
- Buy
- 3
- Hold
- 1
- Sell
- 0
- Strong Sell
- $27.89
- Target Price
Company News
-
Enanta Pharmaceuticals, Inc. (ENTA): Caligan Partners’ Top Holding Right Now? — Aug 9th, 2024
We recently compiled a list of the Top 10 Holdings of Caligan Partners.In this article, we are going to take a look at where Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) stands against Caligan Partners' other top holdings. Founded in 2017, Caligan Partners is one of the most significant spe...
Similar Stocks
No similar stocks found.
|
Portfolio
$5,000/year
Goal: $10,000/year
Comprised of 1 portfolios
$